Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110 062, India.
University Institute of Pharmaceutical Sciences, UGC-Centre of Advanced Studies (CAS), Panjab University, Chandigarh, 160 014, India.
AAPS PharmSciTech. 2021 Feb 7;22(2):66. doi: 10.1208/s12249-021-01939-6.
Complexity and heterogeneous nature of most diseases have posed greater challenges in the modern healthcare system. Fixed-dose combination can offer an ideal way to improve patient compliance and higher therapeutic efficacy. However, biopharmaceutical issues associated with the drug combinations remain unaddressed. Multidrug eutectics (MDE) have demonstrated significant promise in improving the biopharmaceutical attributes with synergistic therapeutic action. Eutectic mixtures are the multicomponent solid forms that possess lesser melting point than the individual components at a fixed composition. Non-covalent linking of drug combinations as MDE is an innovative strategy with enhanced solubility, dissolution, and mechanical and potential therapeutic efficacy. This review provides a comprehensive overview of the design of MDE, rational selection of drugs, characterization tools, and their therapeutic potential. Besides, the futuristic perspective where MDE could make a significant impact on combination therapy is briefly outlined. Graphical Abstract.
大多数疾病的复杂性和异质性给现代医疗保健系统带来了更大的挑战。固定剂量组合可以提供一种理想的方式来提高患者的依从性和更高的治疗效果。然而,与药物组合相关的生物制药问题仍未得到解决。多药共晶(MDE)在改善生物制药特性和协同治疗作用方面表现出了巨大的潜力。共晶混合物是多组分的固体形式,其在固定组成下的熔点低于各个成分。将药物组合以 MDE 的形式进行非共价连接是一种具有增强的溶解度、溶解速率以及机械和潜在治疗效果的创新策略。这篇综述全面概述了 MDE 的设计、药物的合理选择、表征工具及其治疗潜力。此外,还简要概述了 MDE 在联合治疗中可能产生重大影响的未来前景。